Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Michael Jung
AddedMar 31, 2024
UpdatedMay 31, 2026
Michael Jung

Michael Jung

Co-Founder, Pelage Pharma

Crunchbase

Michael Jung's Career

Pelage Pharma
Pelage Pharma

Los Angeles, CA, US

Co-Founder
Athos Therapeutics
Athos Therapeutics

Torrance, CA, US

Co-Founder
Trethera
Trethera

Santa Monica, CA, US

Co-Founder

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Michael Jung's Career

Pelage Pharma
Pelage Pharma
Series B$16.7M7Los Angeles, CA, US
Co-Founder

Leadership at Pelage Pharma

William LowryWilliam LowryCo-Founder
Heather ChristofkHeather ChristofkCo-Founder

Similar to Pelage Pharma

PellePharmPellePharmMenlo Park, CA, USDrugs, Pharmaceuticalsest. 2012PellePharmMenlo Park, CA, US · est. 2012

PellePharm, Inc.: A US-based pharmaceutical company specializing in treatments for basal cell conditions.

Series A · $38.9M11
FollicaFollicaMendham Borough, NJ, USHair Growth, Skin Careest. 2005FollicaMendham Borough, NJ, US · est. 2005

Follica, Inc: Boston-based innovators in hair follicle therapies, skin rejuvenation, and wound healing.

Series B · $24.1M6
AmplificaAmplificaSan Diego, CA, USBiopharmaceuticalsest. 2021AmplificaSan Diego, CA, US · est. 2021

Amplifica: A preclinical biopharmaceutical company innovating alopecia treatments.

Series A · $11.8M5
NutrafolNutrafolNew York City, NY, USHair Growth, Supplementsest. 2014NutrafolNew York City, NY, US · est. 2014

Nutrafol, a leading hair growth supplement brand, offers clinically-backed products targeting root causes of hair health, backed by extensive research.

Series B · $35M304
Athos Therapeutics
Athos Therapeutics
Series A$19.3M152019Torrance, CA, US
Co-Founder

Leadership at Athos Therapeutics

DIMITRIOS ILIOPOULOSDIMITRIOS ILIOPOULOSCo-Founder & CEO
Allan J. PantuckAllan J. PantuckCo-Founder
Trethera
Trethera
Angel$17.4M302015Santa Monica, CA, US
Co-Founder

Leadership at Trethera

Caius RaduCaius RaduCo-Founder
Johannes CzerninJohannes CzerninBoard Member
Owen WitteOwen WitteCo-Founder
Kenneth SchultzKenneth SchultzBoard Member
David NathansonDavid NathansonCo-Founder
Louis GondaLouis GondaBoard Member

Similar to Trethera

Dual TherapeuticsDual TherapeuticsCleveland, OH, USCancer Therapeuticsest. 2012Dual TherapeuticsCleveland, OH, US · est. 2012

Dual Therapeutics: Small-molecule modulator producer for comprehensive cancer treatment.

Series A · $6.6M7
Palm TherapeuticsPalm TherapeuticsSan Diego, CA, USCancer Treatmentest. 2018Palm TherapeuticsSan Diego, CA, US · est. 2018

Revolutionizing cancer treatment with next-gen root-level therapeutics.

Angel · $991.1k7
Soteria BiotherapeuticsSoteria BiotherapeuticsSan Francisco, CA, USCancer Therapiesest. 2018Soteria BiotherapeuticsSan Francisco, CA, US · est. 2018

Soteria: A biotech firm innovating safer, more effective cancer treatments via its T-LITE™ platform.

Series A · $42M11
Nirogy TherapeuticsNirogy TherapeuticsNatick, MA, USDrug Developmentest. 2013Nirogy TherapeuticsNatick, MA, US · est. 2013

Nirogy Therapeutics: Innovating small molecule drugs to target cellular transporters and disrupt tumor growth.

Series A · $18.5M16

Michael Jung's Similar Executives & Operators

Achmad ZakyAchmad ZakyCo-Founder · BukalapakNugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakWILL WEI CHENGWILL WEI CHENGCo-Founder · DiDiBo ZhangBo ZhangCo-Founder · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniFounder · Reliance RetailKim Beom-sooKim Beom-sooCo-Founder · KakaoBrian KimBrian KimCo-Founder · KakaoJB LEEJB LEECo-Founder · Kakao

People Similar to Michael Jung

Tripp FreyTripp FreyCo-Founder · TrewKimmie KoeppelKimmie KoeppelCo-Founder · TreaterJohn RussellJohn RussellFounder · TheragenicsDavid TingDavid TingCo-Founder · TellBio